{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:19Z","timestamp":1787024539123,"version":"build-2736575974"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6140","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T18:08:17Z","timestamp":1469988497000},"page":"2061-2064","source":"Crossref","is-referenced-by-count":9,"title":["Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma"],"prefix":"10.2169","volume":"55","author":[{"given":"Hiroshi","family":"Ureshino","sequence":"first","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsujiro","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Kizuka","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Sano","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takero","family":"Shindo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kubota","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. P\u00e9rez-Callejo D, Gonz\u00e1lez-Rinc\u00f3n J, S\u00e1nchez A, Provencio M, S\u00e1nchez-Beato M. Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas. Cancer Treat Rev 41: 680-689, 2015.","DOI":"10.1016\/j.ctrv.2015.05.007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Griffin MM, Morley N. Rituximab in the treatment of non-Hodgkin's lymphoma-a critical evaluation of randomized controlled trials. Expert Opin Biol Ther 13: 803-811, 2013.","DOI":"10.1517\/14712598.2013.786698"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Salles G, Ghesqui\u00e8res H. Current and future management of follicular lymphoma. Int J Hematol 96: 544-551, 2012.","DOI":"10.1007\/s12185-012-1202-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Okamura I, Imai H, Mori K, et al. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma. Int J Hematol 101: 46-51, 2015.","DOI":"10.1007\/s12185-014-1694-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vogel WH. Infusion reactions: diagnosis, assessment, and management. Clin J Oncol Nurs 14: E10-E21, 2010.","DOI":"10.1188\/10.CJON.E10-E21"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shah C, Grethlein SJ. Case report of rituximab-induced thrombocytopenia. Am J Hematol 75: 263, 2004.","DOI":"10.1002\/ajh.20028"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rosado M, Chao H, Rose M. Severe acute thrombocytopenia following rituximab therapy. Leuk Lymphoma 48: 2239-2240, 2007.","DOI":"10.1080\/10428190701625099"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dhand S, Bahrain H. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature. Cancer Invest 26: 913-915, 2008.","DOI":"10.1080\/07357900802010509"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yi JH, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS. Rituximab-induced acute thrombocytopenia: a case report and review of the literature. Med Oncol 26: 45-48, 2009.","DOI":"10.1007\/s12032-008-9079-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. El-Osta H, Nair B. Rituximab-induced acute thrombocytopenia: an underappreciated entity. Leuk Lymphoma 54: 2736-2737, 2013.","DOI":"10.3109\/10428194.2013.784972"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sadashiv SK, Rao R, Fazal S, Lister J. Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma. Clin Lymphoma Myeloma Leuk 13: 602-605, 2013.","DOI":"10.1016\/j.clml.2013.04.013"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Parajuli R, Hire E, Shah BK. Rituximab-induced acute severe thrombocytopenia. Br J Haematol 149: 804, 2010.","DOI":"10.1111\/j.1365-2141.2010.08119.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ram R, Bonstein L, Gafter-Gvili A, Ben-Bassat I, Shpilberg O, Raanani P. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon. Am J Hematol 84: 247-250, 2009.","DOI":"10.1002\/ajh.21372"},{"key":"14","unstructured":"14. Otrock ZK, Mahfouz RA, Oghlakian GO, Salem ZM, Bazarbachi A. Rituximab-induced acute thrombocytopenia: a report of two cases. Haematologica 90 (Suppl): ECR23, 2005."},{"key":"15","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"15. Maloney DG, Grillo-L\u00f3pez AJ, White CA, et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90: 2188-2195, 1997.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rigamonti C, Volta C, Colombi S, et al. Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion. Leukemia 15: 186-187, 2001.","DOI":"10.1038\/sj.leu.2401987"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kaneko T, Wada H. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. J Clin Exp Hematopathol 51: 67-76, 2011.","DOI":"10.3960\/jslrt.51.67"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Adiyodi J, Thachil J, Hawkins S, Hincks I, Woodcock BE, Salim R. Thrombocytopenia with rituximab treatment--splenomegaly as the risk factor. Ann Hematol 89: 95-96, 2010.","DOI":"10.1007\/s00277-009-0768-9"},{"key":"19","unstructured":"19. Larrar S, Guitton C, Willems M, Bader-Meunier B. Severe hematological side effects following Rituximab therapy in children. Haematologica 91 (8 Suppl): ECR36, 2006."},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Salles G, Seymour JF, Offner F, et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 377: 42-51, 2011.","DOI":"10.1016\/S0140-6736(10)62175-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fujioka Y, Kurokawa M. Follicular lymphoma presenting with massive splenomegaly. Int J Hematol 95: 3-4, 2012.","DOI":"10.1007\/s12185-011-0977-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Koiso H, Yokohama A, Mitsui T, et al. Follicular lymphoma presenting with marked splenomegaly: report of three cases. Acta Haematol 128: 47-52, 2012.","DOI":"10.1159\/000337037"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kotsianidis I, Goutzouvelidis A, Anastasiades A, et al. Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion. Am J Hematol 85: 146, 2010.","DOI":"10.1002\/ajh.21597"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Thachil J, Mukherje K, Woodcock B. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia. Br J Haematol 135: 273-274, 2006.","DOI":"10.1111\/j.1365-2141.2006.06299.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/15\/55_55.6140\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T12:03:25Z","timestamp":1600949005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/15\/55_55.6140\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6140","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}